series-a
Stage
2
Investors
About
Biora Therapeutics develops needle-free oral delivery platforms, including BioJet and NaviCap, to enable targeted delivery of large molecule therapeutics as alternatives to injections for chronic disease management.
Explore Biora Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.